Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation  Noa Nezer M. Sc, David Shoseyov, Eitan.

Slides:



Advertisements
Similar presentations
Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.
Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus  Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
William G. Flight, Jonathan Shaw, Susan Johnson, A
HbA1c as a screening tool for cystic fibrosis related diabetes
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Eitan Kerem, Michael Wilschanski, Nilsen L
Cirrhosis and other liver disease in cystic fibrosis
John Widger, Sarath Ranganathan, Philip J. Robinson 
The ease of breathing test tracks clinical changes in cystic fibrosis
Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET)  Adèle Coriati, Sophie Ziai, Mirna Azar, Yves.
Pulmonary exacerbations in CF patients with early lung disease
Safety and early treatment effects of the CXCR2 antagonist SB in patients with cystic fibrosis  Richard B. Moss, Sunil J. Mistry, Michael W. Konstan,
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Influence of digital clubbing on oxygen saturation measurements by pulse-oximetry in cystic fibrosis patients  Filip Van Ginderdeuren, Karlien Van Cauwelaert,
Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance  L. Merjaneh, Q. He, Q. Long, L.S.
Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: A pilot study  I. Hammana, L. Coderre, S. Potvin, M. Costa,
Vitamin A and lung function in CF
Use of the insulin pump in treat cystic fibrosis related diabetes
Pulmonary nocardiosis in cystic fibrosis
Cytokines in nasal lavages and plasma and their correlation with clinical parameters in cystic fibrosis  Marthe S. Paats, Ingrid M. Bergen, Marleen Bakker,
A.H. Gifford  Journal of Cystic Fibrosis 
Demographics of glucose metabolism in cystic fibrosis
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Cystic fibrosis related diabetes in an extremely young patient
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis  D.W. Reid, R. Latham, I.L.
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Marie-Angela Schnyder, Christian Benden, Christoph Schmid 
Nasal polyposis in lung transplant recipients with cystic fibrosis
Hypertriglyceridemia is associated with insulin levels in adult cystic fibrosis patients  Marie-Claire Ishimo, Linda Belson, Sophie Ziai, Emile Levy, Yves.
Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis  Malena Cohen-Cymberknoh, Noa Gilead, Silvia Gartner, Sandra.
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation  Markus Hofer, Christoph Schmid, Christian Benden, Rudolf Speich,
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
James H. Hull, Rachel Garrod, Timothy B. Ho, Ronald K. Knight, John R
Variation of glucose tolerance in adult patients with cystic fibrosis: What is the potential contribution of insulin sensitivity?  Valérie Boudreau, Adèle.
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis  Malena Cohen-Cymberknoh, Hannah Blau, David Shoseyov,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis  D.J. Touw, A.J. Knox,
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Presentation transcript:

Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation  Noa Nezer M. Sc, David Shoseyov, Eitan Kerem, David Haim Zangen  Journal of Cystic Fibrosis  Volume 9, Issue 3, Pages 199-204 (May 2010) DOI: 10.1016/j.jcf.2010.02.001 Copyright © 2010 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Blood glucose levels in Oral Glucose Tolerance Test – OGTT during pulmonary exacerbation – (triangle) compared to OGTT during the steady state (square). *90 and 120min p=0.0078. Journal of Cystic Fibrosis 2010 9, 199-204DOI: (10.1016/j.jcf.2010.02.001) Copyright © 2010 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 A. Insulin levels during IVGTT in pulmonary exacerbations (triangle) compared to the steady state (square). *3min time point p=0.075. B. Correlation between glucose levels during pulmonary exacerbations (using AUC of OGTT) and the basal insulin secretion capacity (using the early first phase [AUC of 1+3min] insulin secretion of IVGTT) in the steady state. R=−0.64, p=0.09. Journal of Cystic Fibrosis 2010 9, 199-204DOI: (10.1016/j.jcf.2010.02.001) Copyright © 2010 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 Correlation between FEV1 in the steady state and the 2h glucose levels in OGTT during pulmonary exacerbation. R=−0.88, p=0.002. Journal of Cystic Fibrosis 2010 9, 199-204DOI: (10.1016/j.jcf.2010.02.001) Copyright © 2010 European Cystic Fibrosis Society. Terms and Conditions